SEMA3F and breast cancer: The increased expression levels of SEMA3F and NRP2 were confirmed using an in vivo mouse model of MCF10DCIS.com, which was previously described [17]; on day 7, MCF10DCIS.com was found to form DCIS, and on day 29, IDC BC or IDC was already present.